Prothena Corp Public PRTA
NASDAQ PRTA
$8.36 -0.18 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Selling, General & Administrative (2012 - 2026)

Updated

Prothena Corp Public (PRTA) reported Selling, General & Administrative of $10.9 million for Q2 2026, down 31.5% from $15.91 million a year earlier and down 14.0% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) Selling, General & Administrative (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Prothena Corp Public's Selling, General & Administrative came in at $49.45 million, down 26.3% year-over-year; for FY2025, it was $59.39 million, down 11.6% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $67.2 million in FY2024 (+8.7%), $61.84 million in FY2023 (+23.9%), $49.9 million in FY2022 (+7.7%) and $46.32 million in FY2021 (+19.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q4 2020.
  • Year over year, Selling, General & Administrative has now declined in each of the last five quarters, with an average decline of 13.2% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2023 (growth of 38.8%); the low point was Q2 2026 (a decline of 31.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $12.67 million (Q1 2026), $12.65 million (Q4 2025) and $13.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Prothena Corp Public 441.90 Mn -814.18 Mn - 10.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.90 Mn
Mar 31, 2026 12.67 Mn
Dec 31, 2025 12.65 Mn
Sep 30, 2025 13.24 Mn
Jun 30, 2025 15.91 Mn
Mar 31, 2025 17.60 Mn
Dec 31, 2024 16.85 Mn
Sep 30, 2024 16.76 Mn
Jun 30, 2024 16.13 Mn
Mar 31, 2024 17.46 Mn
Dec 31, 2023 16.94 Mn
Sep 30, 2023 16.65 Mn
Jun 30, 2023 14.51 Mn
Mar 31, 2023 13.74 Mn
Dec 31, 2022 13.12 Mn
Sep 30, 2022 11.99 Mn
Jun 30, 2022 12.95 Mn
Mar 31, 2022 11.84 Mn
Dec 31, 2021 12.21 Mn
Sep 30, 2021 11.96 Mn
API Access

Prothena Corp Public Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PRTA&period=max&api_key=YOUR_API_KEY